Uro Gen Pharma
Biotechnology, 400 Alexander Park Dr, Princeton, New Jersey, 08540, United States, 51-200 Employees
Phone Number: 64********
Who is UROGEN PHARMA
UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated because patients deserve better options. Our vi...
Read More
-
Headquarters: 400 Alexander Park Dr, Princeton, New Jersey, 08540, United States
-
Date Founded: 2004
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from UROGEN PHARMA
UroGen Pharma Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding UroGen Pharma
Answer: UroGen Pharma's headquarters are located at 400 Alexander Park Dr, Princeton, New Jersey, 08540, United States
Answer: UroGen Pharma's phone number is 64********
Answer: UroGen Pharma's official website is https://urogen.com
Answer: UroGen Pharma's revenue is $50 Million to $100 Million
Answer: UroGen Pharma's SIC: 2834
Answer: UroGen Pharma has 51-200 employees
Answer: UroGen Pharma is in Biotechnology
Answer: UroGen Pharma contact info: Phone number: 64******** Website: https://urogen.com
Answer: UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated because patients deserve better options. Our vision is grounded in our RTGel drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from pre-clinical to Phase 3, we currently have multiple candidates in our pipeline, which are furthering the study of potential treatment advances in urology, uro-oncology, and immunology. Our collaborative drive: We are part of a broad ecosystem of partners who are seeking to improve patient care; these connections are vital to our commitment to offer new pathways and advance solutions. We are continually evaluating new partnership opportunities.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month